Published in

American Society for Pharmacology and Experimental Therapeutics (ASPET), The Journal of Pharmacology and Experimental Therapeutics, 3(373), p. 476-487, 2020

DOI: 10.1124/jpet.119.263715

Links

Tools

Export citation

Search in Google Scholar

Treatment of Allergic Asthma with Fenretinide Formulation (LAU-7b) Downregulates ORMDL Sphingolipid Biosynthesis Regulator 3 (Ormdl3) Expression and Normalizes Ceramide Imbalance

Journal article published in 2020 by Mina Youssef, Juan B. De Sanctis ORCID, Juhi Shah, Daciana Catalina Dumut, Marian Hajduch, Anna K. Naumova, Danuta Radzioch ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO